For the Inventor, By the Inventor

Enter assignee name

Invectys

USPTO Granted Patents = 10

% Expired Patents = 30.0

EPO Patents = 7

Forward Citations = 13

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Pierre Langlade Demoyen (9 out of 17 patents)

Christelle Liard (6 out of 6 patents)

Simon Wain-Hobson (6 out of 41 patents)

4. Thierry Huet (3 out of 6 patents)

5. Elodie Pliquet (2 out of 3 patents)

6. Olivier Adotevi (2 out of 2 patents)

7. Magalie Dosset (2 out of 2 patents)

8. Julien Caumartin (1 out of 8 patents)

9. Pierre Langlade-Demoyen (1 out of 8 patents)

10. Jessie Thalmensi (1 out of 1 patent)

11. Christophe Calvet (1 out of 1 patent)

12. Anna Kostrzak (1 out of 1 patent)

13. Maria De Las Nieves Loustau (1 out of 1 patent)

14. Luis Maria Mir (1 out of 3 patents)

15. Luis M Mir (0 patent)

10 patents: Sort by Forward Citations

1. 12064474 - Telomerase encoding DNA vaccine (2024-08-20),

2. 10695409 - Universal cancer peptides derived from telomerase (2020-06-30),

3. 10675337 - Cancer vaccine for cats (2020-06-09),

4. 10493154 - Gene electrotransfer into skin cells (2019-12-03),

5. 10183065 - Telomerase encoding DNA vaccine (2019-01-22),

6. 10138488 - Cancer vaccine for dogs (2018-11-27),

7. 10010591 - Method of treating fibrosarcoma using a nucleic acid sequence encoding APOBEC3A (2018-07-03),

8. 10005845 - Antibodies and fragments thereof raised against the alpha-3 domain of HLA-G protein, methods and means for their preparation, and uses thereof (2018-06-26),

9. 9931387 - Cancer vaccine for cats (2018-04-03),

10. 9669080 - Universal cancer peptides derived from telomerase (2017-06-06),

Invectys is a biotechnology company based in Paris, specializing in the development of innovative immunotherapies for cancer treatment. The organization focuses on harnessing the power of the immune system to target and eliminate cancer cells, utilizing advanced research in cellular and molecular biology. With a commitment to addressing unmet medical needs, Invectys aims to improve patient outcomes through its cutting-edge therapeutic approaches, contributing to the evolving landscape of cancer care.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#362 in Paris

#1,710 in France

#55,986 in the World

Invectys

Forward Citations = 13

14 inventors:

Pierre Langlade Demoyen (9 out of 17 patents)

Christelle Liard (6 out of 6 patents)

Simon Wain-Hobson (6 out of 41 patents)

4. Thierry Huet (3 out of 6 patents)

5. Elodie Pliquet (2 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…